15 results on '"Zhu Ling Guo"'
Search Results
2. Mining TCGA database for prognostic genes in head and neck squamous cell carcinoma microenvironment
- Author
-
Qiu-Chi Ran, Sheng-Rong Long, Yan Ye, Chen Xie, Zhuo-Lin XuXiao, Yu-Song Liu, Hong-Xia Pang, Diwas Sunchuri, Nai-Chia Teng, and Zhu-Ling Guo
- Subjects
HNSCC ,Immune scores ,TCGA ,Tumor microenvironment ,Dentistry ,RK1-715 - Abstract
Background/purpose: Head and neck squamous cell carcinoma (HNSCC) is one of the most common malignant tumors. The aim of this study was to elucidate the effect of tumor microenvironment-related genes on the prognosis of HNSCC and to obtain tumor microenvironment-related genes that can predict poor prognosis in HNSCC patients. Materials and methods: The ESTIMATE algorithm was applied to the HNSCC transcriptomic data downloaded from the TCGA (The cancer genome atlas), and then the samples were divided into two groups: high and low immune scoring groups, and high and low basal scoring groups to screen for differentially expressed genes (DEGs) associated with poor patient outcomes. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis was performed to explore the potential functions of DEGs, and then to explore the potential prognostic value of individual DEGs. The results of survival analysis between DEGs and overall survival (OS) to explore tumor microenvironment-related genes relevant to the prognosis of HNSCC patients. Results: Fifty-nine tumor microenvironment-related genes were screened for association of OS with HNSCC (P
- Published
- 2021
- Full Text
- View/download PDF
3. Advanced glycosylated end products restrain the osteogenic differentiation of the periodontal ligament stem cell
- Author
-
Zhu-Ling Guo, Shan-Ling Gan, Chun-Yi Cao, Rao Fu, Sheng-Ping Cao, Chen Xie, Jing-Wei Chen, Alex Gibson, Xu Zheng, and Nai-chia Teng
- Subjects
Dentistry ,RK1-715 - Abstract
Background/purpose: Many studies have confirmed that periodontal disease interacts with diabetes. The aim of this study was to examine whether the advanced glycosylated end products (AGEs), which are generated by diabetics, have important effects on the osteogenic differentiation of periodontal ligament stem cells (PDLSCs). Materials and methods: In this study PDLSCs were isolated from the periodontal ligaments of extracted third molar teeth. The subjects were divided into two groups, which included the normal control group (N-PDLSCs) and the AGEs-stimulating group (A-PDLSCs). Changes of receptor of AGEs (RAGE) and cumulative ROS in PDLSCs were monitored by western blot and flow cytometry, respectively. Results: In the study AGEs noticeably inhibited the osteogenic differentiation of PDLSCs, with significant lower calcification nodules detected in A-PDLSCs (P
- Published
- 2019
- Full Text
- View/download PDF
4. Network pharmacology-based strategy combined with molecular docking to explore the potential mechanism of agarwood against recurrent aphthous stomatitis.
- Author
-
Si-Yu Tao, Hai-Ou Zhang, Qing Yuan, Chu-Xing Li, Xiang Guo, Diwas Sunchuri, and Zhu-Ling Guo
- Published
- 2024
- Full Text
- View/download PDF
5. The novel thiosemicarbazone, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), inhibits neuroblastoma growth in vitro and in vivo via multiple mechanisms
- Author
-
Zhu-Ling Guo, Des R. Richardson, Danuta S. Kalinowski, Zaklina Kovacevic, Kian Cheng Tan-Un, and Godfrey Chi-Fung Chan
- Subjects
Thiosemicarbazone ,di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) ,molecular pharmacology ,cancer treatment ,neuroblastoma ,Diseases of the blood and blood-forming organs ,RC633-647.5 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Neuroblastoma is a relatively common and highly belligerent childhood tumor with poor prognosis by current therapeutic approaches. A novel anti-cancer agent of the di-2-pyridylketone thiosemicarbazone series, namely di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT), demonstrates promising anti-tumor activity. Recently, a second-generation analogue, namely di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), has entered multi-center clinical trials for the treatment of advanced and resistant tumors. The current aim was to examine if these novel agents were effective against aggressive neuroblastoma in vitro and in vivo and to assess their mechanism of action. Methods Neuroblastoma cancer cells as well as immortalized normal cells were used to assess the efficacy and selectivity of DpC in vitro. An orthotopic SK-N-LP/Luciferase xenograft model was used in nude mice to assess the efficacy of DpC in vivo. Apoptosis in tumors was confirmed by Annexin V/PI flow cytometry and H&E staining. Results DpC demonstrated more potent cytotoxicity than Dp44mT against neuroblastoma cells in a dose- and time-dependent manner. DpC significantly increased levels of phosphorylated JNK, neuroglobin, cytoglobin, and cleaved caspase 3 and 9, while decreasing IkBα levels in vitro. The contribution of JNK, NF-ĸB, and caspase signaling/activity to the anti-tumor activity of DpC was verified by selective inhibitors of these pathways. After 3 weeks of treatment, tumor growth in mice was significantly (p
- Published
- 2016
- Full Text
- View/download PDF
6. Network pharmacology and molecular docking-based investigation on traditional Chinese medicine Astragalus membranaceus in oral ulcer treatment.
- Author
-
Wan Zhong, Si-Yu Tao, Xiang Guo, Xiao-Fang Cheng, Qing Yuan, Chu-Xing Li, Hong-Yuan Tian, Song Yang, Diwas Sunchuri, and Zhu-Ling Guo
- Published
- 2023
- Full Text
- View/download PDF
7. Advances in studies on the regulation of periodontal disease by highdensity lipoprotein
- Author
-
Zhu-Ling Guo
- Subjects
lipopolysaccharide ,lcsh:R ,lcsh:Medicine ,lipids (amino acids, peptides, and proteins) ,high-density lipoprotein ,periodontitis - Abstract
Many studies in recent years have considered the potential relationship between periodontitis and lipid parameters. Currently, it is generally accepted that HDL (High-density lipoprotein) is one of the lipoproteins that play an important role in immunity and an important part of maintaining periodontal homeostasis. In this paper, the protective mechanism of HDL in periodontitis was discussed, and the adjuvant therapeutic effect of HDL in periodontitis with systemic disease was emphasized.
- Published
- 2020
8. Study on the mechanism of Porphyromonas gingivalis pili mediated ather osclerosis
- Author
-
Zhu-Ling Guo and Qi-Ya Fu
- Subjects
porphyromonas gingivalis ,lcsh:R ,lcsh:Medicine ,pili ,chronic periodontitis ,atherosclerosis - Abstract
Chronic periodontitis is the most common infectious periodontal disease caused by plaque biofilm. Pili is an important bacterial component of Porphyromonas gingivalis. Epidemiological studies have shown that chronic periodontitis can increase the risk of cardiovascular disease, and atherosclerosis is the pathological basis of cardiovascular disease. This article will summarize the mechanism of Porphyromonas gingivalis pili protein mediated chronic periodontitis and atherosclerosis, in order to expand new ideas of disease prevention and treatment.
- Published
- 2020
9. Salivary Pro-Inflammatory Markers and Smoking Status Influences the Treatment Effectiveness of Periodontal Disease Patients with Hypertension
- Author
-
Yung Kai Huang, Chang-Yu Lee, I-Hui Chen, Kun-Tsung Lee, Kuei-Ling Christine Hsu, Hung-Ming Chang, Nai-Chia Teng, and Zhu-Ling Guo
- Subjects
0301 basic medicine ,Saliva ,medicine.medical_specialty ,Health, Toxicology and Mutagenesis ,Bleeding on probing ,scaling and root planning ,Plaque control ,Gastroenterology ,Article ,03 medical and health sciences ,0302 clinical medicine ,Periodontal disease ,Recovery rate ,plaque control ,Internal medicine ,medicine ,Humans ,non-surgical periodontal therapy ,Periodontal Diseases ,Periodontitis ,inflammation and innate immunity ,business.industry ,Smoking ,Public Health, Environmental and Occupational Health ,cytokine(s) ,030206 dentistry ,medicine.disease ,030104 developmental biology ,Treatment Outcome ,Hypertension ,Medicine ,Observational study ,Smoking status ,medicine.symptom ,business ,Biomarkers - Abstract
Background: Hypertension and periodontal diseases share several risk factors. Inflammation biomarkers in saliva are related to hypertension and periodontal disease. The aim of this study was to explore the role of the salivary inflammatory biomarkers in the treatment effectiveness of patients with hypertension and periodontal disease. Methods: This observational study enrolled 160 subjects diagnosed with periodontitis, 40 of which had a history of hypertension. All subjects had completed scaling and root planning therapeutic procedures within four weeks. The clinical periodontal parameters (i.e., bleeding on probing, plaque control record (PCR), and probing depth (PD)) were evaluated before and after the treatment. Pro-inflammatory markers were determined using a commercial kit. Results: The recovery rate (PD 4–9 mm) in non-hypertensive subjects was significantly higher than in hypertensive subjects (60.47% vs. 52.60%, respectively, p = 0.04). All clinical parameters, excluding PCR, positively correlated with salivary IL-1β at baseline and after completing treatment. Our results showed that increased salivary IL-1β levels were positively associated with decreased PCR (β = −27.65 and p = 0.05) and PD recovery rate (β = −17.05 and p = 0.02) in hypertensive subjects. Conclusions: The present study sheds important light on the clinical use of salivary pro-inflammatory cytokines as valuable biomarkers for predicting the treatment effectiveness of patients suffering from hypertension and periodontitis.
- Published
- 2021
- Full Text
- View/download PDF
10. Advanced glycosylated end products restrain the osteogenic differentiation of the periodontal ligament stem cell
- Author
-
Alex Gibson, Zhu Ling Guo, Shan Ling Gan, Rao Fu, Xu Zheng, Sheng Ping Cao, Nai Chia Teng, Chun Yi Cao, Chen Xie, and Jing Wei Chen
- Subjects
Molar ,Periodontal ligament stem cells ,PDLSCs (periodontal ligament stem cells) ,Flow cytometry ,Andrology ,03 medical and health sciences ,Diabetes mellitus ,0302 clinical medicine ,Western blot ,medicine ,Periodontal fiber ,General Dentistry ,medicine.diagnostic_test ,business.industry ,Prevention ,030206 dentistry ,AGEs (advanced glycosylated end products) ,medicine.disease ,lcsh:RK1-715 ,Apoptosis ,030220 oncology & carcinogenesis ,lcsh:Dentistry ,Original Article ,Periodontal disease ,Stem cell ,business ,Calcification - Abstract
Background/purpose: Many studies have confirmed that periodontal disease interacts with diabetes. The aim of this study was to examine whether the advanced glycosylated end products (AGEs), which are generated by diabetics, have important effects on the osteogenic differentiation of periodontal ligament stem cells (PDLSCs). Materials and methods: In this study PDLSCs were isolated from the periodontal ligaments of extracted third molar teeth. The subjects were divided into two groups, which included the normal control group (N-PDLSCs) and the AGEs-stimulating group (A-PDLSCs). Changes of receptor of AGEs (RAGE) and cumulative ROS in PDLSCs were monitored by western blot and flow cytometry, respectively. Results: In the study AGEs noticeably inhibited the osteogenic differentiation of PDLSCs, with significant lower calcification nodules detected in A-PDLSCs (P
- Published
- 2019
11. The novel thiosemicarbazone, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), inhibits neuroblastoma growth in vitro and in vivo via multiple mechanisms
- Author
-
Godfrey Chi-Fung Chan, Des R. Richardson, Zhu-Ling Guo, Danuta S. Kalinowski, Kian Cheng Tan-Un, and Zaklina Kovacevic
- Subjects
0301 basic medicine ,Cancer Research ,Caspase 3 ,Pharmacology ,Thiosemicarbazone ,lcsh:RC254-282 ,cancer treatment ,03 medical and health sciences ,neuroblastoma ,Annexin ,In vivo ,Neuroblastoma ,Medicine ,di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) ,Cytotoxicity ,Molecular Biology ,Caspase ,biology ,business.industry ,lcsh:RC633-647.5 ,Research ,molecular pharmacology ,Hematology ,lcsh:Diseases of the blood and blood-forming organs ,medicine.disease ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,3. Good health ,030104 developmental biology ,Oncology ,Apoptosis ,Cancer cell ,biology.protein ,business - Abstract
Background Neuroblastoma is a relatively common and highly belligerent childhood tumor with poor prognosis by current therapeutic approaches. A novel anti-cancer agent of the di-2-pyridylketone thiosemicarbazone series, namely di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT), demonstrates promising anti-tumor activity. Recently, a second-generation analogue, namely di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), has entered multi-center clinical trials for the treatment of advanced and resistant tumors. The current aim was to examine if these novel agents were effective against aggressive neuroblastoma in vitro and in vivo and to assess their mechanism of action. Methods Neuroblastoma cancer cells as well as immortalized normal cells were used to assess the efficacy and selectivity of DpC in vitro. An orthotopic SK-N-LP/Luciferase xenograft model was used in nude mice to assess the efficacy of DpC in vivo. Apoptosis in tumors was confirmed by Annexin V/PI flow cytometry and H&E staining. Results DpC demonstrated more potent cytotoxicity than Dp44mT against neuroblastoma cells in a dose- and time-dependent manner. DpC significantly increased levels of phosphorylated JNK, neuroglobin, cytoglobin, and cleaved caspase 3 and 9, while decreasing IkBα levels in vitro. The contribution of JNK, NF-ĸB, and caspase signaling/activity to the anti-tumor activity of DpC was verified by selective inhibitors of these pathways. After 3 weeks of treatment, tumor growth in mice was significantly (p
- Published
- 2016
- Full Text
- View/download PDF
12. Simulation and Statistical Modeling of Acoustic Scattering of Bubble Wakes
- Author
-
Cao Qing-Gang, Zhu Ling-Guo, Wang Jin, Yang Bao-Shan, Ma Zhong-cheng, and Zhao An-Bang
- Subjects
Article Subject ,General Mathematics ,Bubble ,Acoustics ,lcsh:Mathematics ,Sea trial ,General Engineering ,Feature recognition ,Statistical model ,Wake ,Tracking (particle physics) ,lcsh:QA1-939 ,01 natural sciences ,Sonar ,010101 applied mathematics ,010309 optics ,lcsh:TA1-2040 ,0103 physical sciences ,0101 mathematics ,Underwater ,lcsh:Engineering (General). Civil engineering (General) ,Geology - Abstract
Ship wakes are large, exist for a long time, and are difficult to disguise or conceal. These characteristics can be used as an important basis for ship tracking and recognition. However, distinguishing between wakes, underwater targets, and sea surface is a difficult problem that currently limits acoustic wake homing technology. To solve this problem, in this study, from the viewpoint of feature recognition, the effects of bubble radius, air volume fraction, frequency, depth, and other parameters on the group bubble were first investigated. The volume scattering intensity of acoustic wakes at different frequencies and depths was also calculated and analyzed, and the results of our theoretical calculations were verified through an experiment using a multifrequency single wave sonar dock. Subsequently, through the single frequency and multibeam sonar sea trial test, a statistical model of target characteristics with a clear physical mechanism was developed. The developed model can be utilized for the guidance and recognition of acoustic wake targets. Thus, this study lays the foundation for the practical application of acoustic wake guidance.
- Published
- 2018
13. Experimental Study on Echo Characteristics of Multistatic Large-Scale Underwater Complex Target
- Author
-
Wang Shu-tao, Zhu Ling-Guo, Ma Zhong-cheng, Zhao An-Bang, Han Jing, and Liu Wen-zhang
- Subjects
Physics ,0209 industrial biotechnology ,Article Subject ,Scattering ,General Mathematics ,Acoustics ,lcsh:Mathematics ,General Engineering ,02 engineering and technology ,lcsh:QA1-939 ,Experimental research ,Azimuth ,Superposition principle ,020901 industrial engineering & automation ,lcsh:TA1-2040 ,0202 electrical engineering, electronic engineering, information engineering ,020201 artificial intelligence & image processing ,Underwater ,lcsh:Engineering (General). Civil engineering (General) - Abstract
Target acoustic scattering is the primary characteristic of target echo stealth performance, and it is an important sign of the viability of large-scale complex targets underwater. In a test band, owing to the superposition of scattered waves and the elastic echo produced by shells, liquid tanks, partition plates, ribs, etc., a target exhibits an extremely complex echo phenomenon. Accurate measurement and evaluation of the acoustic scattering characteristics of underwater complex targets can be achieved via experimental research on the echo characteristics of large-scale scaled models. In this study, the contribution and regularity of the strong reflection source of underwater complex targets in various azimuths, structures, and locations were analyzed quantitatively as a basis for in-depth research and understanding of the echo characteristics of underwater complex targets.
- Published
- 2018
14. Advances in studies on the regulation of periodontal disease by high-density lipoprotein.
- Author
-
Zhu-Ling Guo, Wan-Yun Lin, Chen Xie, and Qi-Ya Fu
- Subjects
PERIODONTAL disease ,LIPOPROTEINS ,LIPOPOLYSACCHARIDES ,HIGH density lipoproteins ,HOMEOSTASIS - Abstract
Many studies in recent years have considered the potential relationship between periodontitis and lipid parameters. Currently, it is generally accepted that HDL (High-density lipoprotein) is one of the lipoproteins that play an important role in immunity and an important part of maintaining periodontal homeostasis. In this paper, the protective mechanism of HDL in periodontitis was discussed, and the adjuvant therapeutic effect of HDL in periodontitis with systemic disease was emphasized. [ABSTRACT FROM AUTHOR]
- Published
- 2020
15. Genetically modified "obligate" anaerobic Salmonella typhimurium as a therapeutic strategy for neuroblastoma.
- Author
-
Zhu-Ling Guo, Bin Yu, Bo-Tao Ning, Shing Chan, Qiu-Bin Lin, James Chun-Bong Li, and Jian-Dong Huang
- Subjects
- *
SALMONELLA typhimurium , *NEUROBLASTOMA , *MICROBIAL genetic engineering , *IMMUNODEFICIENCY , *LABORATORY mice , *PROGNOSIS - Abstract
Background: Neuroblastoma currently has poor prognosis, therefore we proposed a new strategy by targeting neuroblastoma with genetically engineered anaerobic Salmonella (Sal-YB1). Methods: Nude and nonobese diabetic-severe combined immunodeficiency (NOD-SCID) orthotopic mouse models were used, and Sal-YB1 was administered via tail vein. The therapeutic effectiveness, bio-safety, and mechanisms were studied. Results: No mice died of therapy-related complications. Tumor size reduction was 70 and 30 % in nude and NOD-SCID mice, respectively. No Salmonella was detected in the urine; 75 % mice had positive stool culture if diaminopimelic acid was added, but all turned negative subsequently. Tumor tissues had more Sal-YB1 infiltration, necrosis, and shrinkage in Sal-YB1-treated mice. Significantly higher expression of TLR4, TNF-stimulated gene 6 protein (TSG6), and cleaved caspase 1, 3, 8, and 9 was found in the tumor masses of the Sal-YB1-treated group with a decrease of interleukin 1 receptor-associated kinase (IRAK) and nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor alpha (IκBα). There was a high release of TNFα both in human macrophages and mouse tumor tissues with Sal-YB1 treatment. The antitumor effect of the supernatant derived from macrophages treated with Sal-YB1 could be reversed with TNFa and pan-caspase inhibitors. Conclusions: This new approach in targeting neuroblastoma by bio-engineered Salmonella with the assistance of macrophages indirectly may have a clinical therapeutic impact in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.